Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
8.02
-0.49 (-5.76%)
Nov 20, 2026, 3:04 PM CST
SHE:301060 Market Cap
SHE:301060 has a market cap or net worth of 3.2 billion as of November 20, 2026. It is the 13,995th most valuable company in the world and the 3,564th biggest in China. Its market cap has decreased by 20.28% in one year.
Market Cap
3.20B
Enterprise Value
2.54B
Revenue
1.24B
Global Rank
Country Rank
#3,564 China
PE Ratio
76.08
ChartMarket Cap Chart
Since September 13, 2021, SHE:301060's market cap has decreased from 7.32B to 3.20B, a decrease of -56.32%. That is a compound annual growth rate of -14.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.20B | -13.30% |
| Dec 31, 2025 | 3.69B | 1.45% |
| Dec 31, 2024 | 3.63B | -31.73% |
| Dec 29, 2023 | 5.32B | -32.23% |
| Dec 30, 2022 | 7.85B | -43.54% |
| Dec 31, 2021 | 13.91B | 90.09% |
| Sep 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Strong Biotechnologies,Inc. | 7.00B |
| Amoy Diagnostics | 6.29B |
| Shanghai Runda Medical Technology | 4.42B |
| Cowealth Medical China | 3.41B |
| Medicalsystem Biotechnology | 3.22B |
| Guangdong Hybribio Biotech | 2.93B |
| Thalys Medical Technology Group | 2.73B |
| Berry Genomics Co.,Ltd | 2.64B |